Cognitive Functioning in Patients with Neuro-PASC: the Role of Fatigue, Mood, and Hospitalization Status

Overview

Journal Front Neurol

Specialty Neurology

Date 2024 Jul 12

PMID 38994492

Authors

Joshua Cahan

John-Christopher A Finley

Erica Cotton

Zachary S Orban

Millenia Jimenez

Sandra Weintraub

Tali Sorets

Igor J Koralnik

Affiliations

Soon will be listed here.

Abstract

This study sought to characterize cognitive functioning in patients with neurological post-acute sequelae of SARS-CoV-2 infection (Neuro-PASC) and investigate the association of subjective and objective functioning along with other relevant factors with prior hospitalization for COVID-19. Participants were 106 adult outpatients with Neuro-PASC referred for abbreviated neuropsychological assessment after scoring worse than one standard deviation below the mean on cognitive screening. Of these patients, 23 had been hospitalized and 83 had not been hospitalized for COVID-19. Subjective cognitive impairment was evaluated with the self-report cognition subscale from the Patient-Reported Outcome Measurement Information System. Objective cognitive performance was assessed using a composite score derived from multiple standardized cognitive measures. Other relevant factors, including fatigue and depression/mood symptoms, were assessed via the Patient-Reported Outcome Measurement Information System. Subjective cognitive impairment measures exceeded the minimal difficulties noted on objective tests and were associated with depression/mood symptoms as well as fatigue. However, fatigue independently explained the most variance (17.51%) in patients' subjective cognitive ratings. When adjusting for fatigue and time since onset of COVID-19 symptoms, neither objective nor subjective impairment were associated with prior hospitalization for COVID-19. Findings suggest that abbreviated neuropsychological assessment may not reveal objective difficulties beyond initial cognitive screening in patients with Neuro-PASC. However, subjective cognitive concerns may persist irrespective of hospitalization status, and are likely influenced by fatigue and depression/mood symptoms. The impact of concomitant management of fatigue and mood in patients with Neuro-PASC who report cognitive concerns deserve further study.

References

McWhirter L, Smyth H, Hoeritzauer I, Couturier A, Stone J, Carson A . What is brain fog?. J Neurol Neurosurg Psychiatry. 2023; 94(4):321-325. DOI: 10.1136/jnnp-2022-329683. View

Pihlaja R, Kauhanen L, Ollila H, Tuulio-Henriksson A, Koskinen S, Tiainen M . Associations of subjective and objective cognitive functioning after COVID-19: A six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav Immun Health. 2023; 27:100587. PMC: 9812472. DOI: 10.1016/j.bbih.2023.100587. View

Maltezou H, Pavli A, Tsakris A . Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines (Basel). 2021; 9(5). PMC: 8151752. DOI: 10.3390/vaccines9050497. View

Pallanti S, Di Ponzio M, Gavazzi G, Gasic G, Besteher B, Heller C . From 'mental fog' to post-acute COVID-19 syndrome's executive function alteration: Implications for clinical approach. J Psychiatr Res. 2023; 167:10-15. DOI: 10.1016/j.jpsychires.2023.09.017. View

Graham E, Clark J, Orban Z, Lim P, Szymanski A, Taylor C . Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021; 8(5):1073-1085. PMC: 8108421. DOI: 10.1002/acn3.51350. View

Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022; 604(7907):697-707. PMC: 9046077. DOI: 10.1038/s41586-022-04569-5. View

Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S . The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol. 2010; 63(11):1179-94. PMC: 2965562. DOI: 10.1016/j.jclinepi.2010.04.011. View

Diez-Cirarda M, Yus M, Gomez-Ruiz N, Polidura C, Gil-Martinez L, Delgado-Alonso C . Multimodal neuroimaging in post-COVID syndrome and correlation with cognition. Brain. 2022; 146(5):2142-2152. PMC: 9620345. DOI: 10.1093/brain/awac384. View

Collantes M, Espiritu A, Sy M, Anlacan V, Jamora R . Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2020; 48(1):66-76. PMC: 7492583. DOI: 10.1017/cjn.2020.146. View

10.

Mina Y, Enose-Akahata Y, Hammoud D, Videckis A, Narpala S, OConnell S . Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol Neuroimmunol Neuroinflamm. 2023; 10(4). PMC: 10162706. DOI: 10.1212/NXI.0000000000200097. View

11.

Whiteside D, Basso M, Naini S, Porter J, Holker E, Waldron E . Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning. Clin Neuropsychol. 2022; 36(4):806-828. DOI: 10.1080/13854046.2022.2030412. View

12.

Hellmuth J, Barnett T, Asken B, Kelly J, Torres L, Stephens M . Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021; 27(1):191-195. PMC: 7852463. DOI: 10.1007/s13365-021-00954-4. View

13.

Cipolli G, Alonso V, Yasuda C, de Assumpcao D, Cachioni M, Melo R . Cognitive impairment in post-acute COVID-19 syndrome: a scoping review. Arq Neuropsiquiatr. 2023; 81(12):1053-1069. PMC: 10756850. DOI: 10.1055/s-0043-1777115. View

14.

Ong I, Kolson D, Schindler M . Mechanisms, Effects, and Management of Neurological Complications of Post-Acute Sequelae of COVID-19 (NC-PASC). Biomedicines. 2023; 11(2). PMC: 9953707. DOI: 10.3390/biomedicines11020377. View

15.

Mrazik M, Millis S, Drane D . The oral trail making test: effects of age and concurrent validity. Arch Clin Neuropsychol. 2010; 25(3):236-43. PMC: 2858599. DOI: 10.1093/arclin/acq006. View

16.

Premraj L, Kannapadi N, Briggs J, Seal S, Battaglini D, Fanning J . Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022; 434:120162. PMC: 8798975. DOI: 10.1016/j.jns.2022.120162. View

17.

Liu Y, Chen Y, Wang Q, Wang L, Jiang L, Yang Y . One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol. 2022; 79(5):509-517. PMC: 8905512. DOI: 10.1001/jamaneurol.2022.0461. View

18.

Krishnan K, Miller A, Reiter K, Bonner-Jackson A . Neurocognitive Profiles in Patients With Persisting Cognitive Symptoms Associated With COVID-19. Arch Clin Neuropsychol. 2022; 37(4):729-737. PMC: 8903427. DOI: 10.1093/arclin/acac004. View

19.

Sobrino-Relano S, Balboa-Bandeira Y, Pena J, Ibarretxe-Bilbao N, Zubiaurre-Elorza L, Ojeda N . Neuropsychological deficits in patients with persistent COVID-19 symptoms: a systematic review and meta-analysis. Sci Rep. 2023; 13(1):10309. PMC: 10293265. DOI: 10.1038/s41598-023-37420-6. View

20.

Bailey J, Lavelle B, Miller J, Jimenez M, Lim P, Orban Z . Multidisciplinary Center Care for Long COVID Syndrome-A Retrospective Cohort Study. Am J Med. 2023; 138(1):108-120. PMC: 10200714. DOI: 10.1016/j.amjmed.2023.05.002. View